Barbara H. Ryland
Overview
Barbara H. Ryland is a senior counsel in the Washington office of Crowell & Moring's Health Care Group. Ms. Ryland brings more than 20 years of experience navigating the complex health care regulatory environment in working with health care clients in counseling, litigation and internal investigations.
Career & Education
- University of Virginia, 1983
- Duke University School of Law, 1987
- District of Columbia
- Maryland
Barbara's Insights
Blog Post | 02.06.23
Firm News | 1 min read | 07.22.22
Crowell & Moring Advises Amazon in its $3.9 Billion Acquisition of One Medical
Blog Post | 05.04.22
Representative Matters
Representative Fraud and Abuse Matters
- Counseling and review of fraud and abuse related issues for physician incentive initiative for ESRD patients.
- Drafting and review of comments on proposed rules to add value based safe harbors.
- Fraud and abuse counseling and “Best Price” impact of value based arrangements between plans and/or purchasers and pharmaceutical manufacturers.
Representative FCA Matters
- Defending Inpatient Rehabilitation Facility (IRF) against allegations of incorrect coding in order to meet CMS threshold for maintaining IRF status.
- Defending Medicare Advantage Organization (MAO) against allegations of false certification of bid information; network adequacy; and failure to meet “model of care” requirements for special needs plans.
- Defending hospital against claim for vicarious FCA liability with respect to physician who engaged in deliberately incorrect coding in order to bill for “routine” visits otherwise not covered under Medicare.
Representative Pharmacy/Pharmaceutical Related Work
- Ongoing counseling including regulatory comments on administration initiatives, including proposed amendments to Discount Safe Harbor to exclude rebates; ANPRM for the International Pricing Index (IPI) Model for Part B Drugs; and Proposed Rule for Importation of Drugs from Canada.
- Regulatory and contracting support related to 340B pricing disputes between plans, purchasers, and pharmaceutical manufacturers.
- Due diligence and licensure transfer in acquisition of national specialty pharmacy.
Barbara's Insights
Blog Post | 02.06.23
Firm News | 1 min read | 07.22.22
Crowell & Moring Advises Amazon in its $3.9 Billion Acquisition of One Medical
Blog Post | 05.04.22
Barbara's Insights
Blog Post | 02.06.23
Firm News | 1 min read | 07.22.22
Crowell & Moring Advises Amazon in its $3.9 Billion Acquisition of One Medical
Blog Post | 05.04.22